Source: Eur Respir J 2015; 46: 1840-1841
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Guthrie Jennifer L., Gardy Jennifer L.. Accelerating tuberculosis elimination in low-incidence settings: the role of genomics. Eur Respir J 2015; 46: 1840-1841

Member's Comments

No comment yet.

Related content which might interest you: Towards tuberculosis elimination: an action framework for low-incidence countries Source: Eur Respir J 2015; 45: 928-952 Year: 2015 Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination Source: Eur Respir J 2015; 45: 289-291 Year: 2015 A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosis Source: Eur Respir J 2014; 43: 632-635 Year: 2013 Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice Source: Eur Respir J 2011; 37: 1175-1182 Year: 2011 Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection Source: Eur Respir J 2010; 36: 1242-1247 Year: 2010 Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries Source: Eur Respir J , 49 (2) 1602242; DOI: 10.1183/13993003.02242-2016 Year: 2017 Childhood tuberculosis: progress requires an advocacy strategy now Source: Eur Respir J 2012; 40: 294-297 Year: 2012 Towards the elimination of tuberculosis: challenges ahead from a European perspective Source: Annual Congress 2012 - Joint session with WHO and ECDC "Towards elimination of tuberculosis" Year: 2012 Mobilising community networks for early identification of tuberculosis and treatment initiation in Cambodia: an evaluation of a seed-and-recruit model Source: ERJ Open Res, 6 (2) 00368-2019; 10.1183/23120541.00368-2019 Year: 2020 TB "cross-border" - a new challenge in tuberculosis management Source: Virtual Congress 2020 – Tuberculosis and society Year: 2020 A global strategy for tuberculosis research and innovation Source: Eur Respir J, 56 (5) 2003539; 10.1183/13993003.03539-2020 Year: 2020 Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia Source: Eur Respir J, 52 (6) 1801218; 10.1183/13993003.01218-2018 Year: 2018 Comparison of tuberculosis surveillance systems in low-incidence industrialised countries Source: Eur Respir J 2008; 32: 1616-1624 Year: 2008 Multidrug-resistant tuberculosis around the world: what progress has been made? Source: Eur Respir J 2015; 45: 150-160 Year: 2015 Preventing the spread of TB among trans-Mediterranean migrants: the role of therapeutic education Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018 Characterization of extensively drug-resistant mycobacterium tuberculosis in Siberia Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Countrywide implementation of whole genome sequencing: an opportunity to improve tuberculosis management, surveillance and contact tracing in low incidence countries Source: Eur Respir J, 51 (6) 1800387; 10.1183/13993003.00387-2018 Year: 2018 Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control Source: Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017 Year: 2017